SKI Market

Indian Indices

Nifty

26,033.75 47.75
(0.18%)

Sensex

85,265.32 158.51
( 0.19%)

Bank Nifty

59,288.70 -59.55
( -0.10%)

Nifty IT

38,360.25 535.00
( 1.41%)

Global Indices

Nasdaq

47,916.06 420.60
(0.89%)

Dow Jones

6,872.48 22.11
(0.32%)

Hang Seng

50,935.81 1,071.13
(2.15%)

Nikkei 225

9,722.32 30.25
(0.31%)

Forex

USD-INR

89.86 0.31
(0.35%)

EUR-INR

104.33 0.34
(0.33%)

GBP-INR

118.66 0.22
(0.18%)

JPY-INR

0.58 0.00
(0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532989

INE878I01022

38.5638498

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BAFNAPH

34.09

360.52

EPS(TTM)

Face Value()

Div & Yield %

4.47

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	145.86	152.47	115.35	85.14	71.22	42.47
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	145.86	152.47	115.35	85.14	71.22	42.47
Other Income	2.74	3.52	3.27	1.70	0.75	0.26
Stock Adjustments	-6.45	4.85	2.91	1.77	-2.95	3.24
Total Income	142.15	160.84	121.53	88.61	69.02	45.97
EXPENDITURE :
Raw Materials	74.49	91.58	65.98	41.70	33.58	23.22
Power & Fuel Cost	7.72	6.73	5.31	3.93	2.95	2.69
Employee Cost	21.03	19.03	15.87	14.65	11.98	10.25
Other Manufacturing Expenses	14.83	13.83	8.68	7.72	6.72	5.02
Selling & Administrative Expenses	9.37	13.98	5.39	6.92	2.67	3.18
Miscellaneous Expenses	2.94	1.06	1.33	2.19	0.07	23.45
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	130.38	146.20	102.55	77.11	57.97	67.80
Operating Profit	11.77	14.63	18.99	11.50	11.04	-21.84
Interest	2.73	2.29	2.04	0.79	0.74	0.10
Gross Profit	9.04	12.34	16.95	10.71	10.30	-21.94
Depreciation	4.89	5.00	5.33	5.49	4.48	3.27
Profit Before Tax	4.15	7.34	11.62	5.22	5.82	-25.21
Tax	0.00	0.00	0.28	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	4.15	7.35	11.34	5.22	5.83	-25.20
Extraordinary Items	-2.22	0.07	0.20	-2.16	0.00	-23.33
Adjusted Net Profit	6.37	7.28	11.14	7.38	5.83	-1.87
Adjustment below Net Profit	-0.19	0.04	0.15	-0.02	0.00	0.00
P & L Balance brought forward	-47.10	-54.48	-65.97	-71.17	-76.99	-51.79
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-43.13	-47.10	-54.48	-65.97	-71.17	-76.99
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.76	3.11	4.79	2.21	2.46	-106.54
Earnings Per Share(Adj)-Unit Curr	1.76	3.11	4.79	2.21	2.46	-106.54
Book Value-Unit Curr	35.85	34.17	31.05	26.19	24.00	-18.64
Book Value(Adj)-Unit Curr	35.85	34.17	31.05	26.19	24.00	-18.64

26,033.75 47.75 (0.18%)

85,265.32 158.51 ( 0.19%)

59,288.70 -59.55 ( -0.10%)

38,360.25 535.00 ( 1.41%)

47,916.06 420.60 (0.89%)

6,872.48 22.11 (0.32%)

50,935.81 1,071.13 (2.15%)

9,722.32 30.25 (0.31%)

89.86 0.31 (0.35%)

104.33 0.34 (0.33%)

118.66 0.22 (0.18%)

0.58 0.00 (0.04%)